CDK1 and prostate carcinoma: CDK1 and CDK2, two cell cycle regulatory protein kinases important for the G1 to S and G2 to M cell cycle transitions, respectively, interact to phosphorylate FOXO1 at Ser 249 (S249) in prostate cancer cells [51], [52].